Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP)
Recruiting
Observational Study
Thrombotic Thrombocytopenic Purpura (TTP)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 44 (estimated)
- Sponsor
- University Hospital, Rouen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The general objective of the proposed project is to characterise phenotypically and functionally ADAMTS13-specific memory B lymphocytes and autoreactive T lymphocytes, in particular follicular helper T lymphocytes, in the acute phase of the disease, but also during its progression after treatment. The aim is to highlight their contribution to the initial pathogenic process, their evolution under t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age over 18
* patients with TTP at any stage of diagnosis (acute phase, lasting remission or not, relapse)
* patients undergoing internal medicine at Rouen University Hospital
* people who have read and understood the information letter
* membership of a social security scheme…
Contacts